December 3, 2024 - Revelation Biosciences Inc. Announces Exercise of Warrants for $4 Million in Gross Proceeds
December 2, 2024 - Revelation Biosciences Inc. Announces FDA Acceptance of Gemini IND
November 12, 2024 - Revelation Biosciences, Inc. Completes the GMP Manufacture of Gemini Clinical Drug Supply
November 8, 2024 - Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2024
